Diagnostics

A new long-term deal for the INTERCEPT system highlights a critical shift towards proactive pathogen reduction to protect France's blood supply from global threats.

A landmark study reveals essential phospholipids significantly reduce liver fat and fatigue in MASLD patients, offering a new tool against a silent epidemic.

Medicana Health Group aims for 25,000 HPV shots annually, stepping into a major public health gap. But can this private initiative overcome cost barriers?

One of the nation's largest dental groups just erased over a billion in debt. This move reveals the high-stakes finance behind your dentist's office.

A landmark $41M donation from the Weston family to Sunnybrook aims to overhaul Canada's clinical trial landscape, promising faster patient access to therapies.

Top expert Dr. Henrik Zetterberg joins Circular Genomics, signaling a pivotal shift toward novel circular RNA blood tests for neurodegenerative disease.

A new study reveals that poor muscle quality, measured by advanced MRI, is a powerful predictor of death in CKD patients, shifting focus to systemic health.

A medtech startup received a major NIH award to develop a wearable AI that predicts SUDEP, a deadly complication of epilepsy, offering new hope for patients.

Akumin unveils its renovated Plantation facility, blending advanced United Imaging tech with patient-centered design to set a new standard for diagnostics.

A new non-viral gene therapy targeting iron buildup in the eye has completed its Phase I trial, offering a potential new path for millions with dry AMD.

A new patient registry for a wireless, catheter-free device is set to power AI, promising a more accurate and dignified future for urological care.

The Health Research Foundation opens nominations for its equity award, spotlighting researchers who are closing critical health gaps for diverse communities.

By manufacturing its own drug test cups, 12PanelNow bypasses distributors, promising lower costs and greater reliability for critical testing needs.

Korean brand Dr. Reju-All's pharmacist-led approach and PDRN science captivated nearly 5,000 dermatologists, signaling a new wave in U.S. skincare.

A Montreal agency’s innovative campaign for DEX4 is changing the conversation around hypoglycemia by turning a moment of anxiety into an act of empowerment.

From an AI-powered undersea lab to shaping global shark laws, discover how one university is leading a multi-front battle to save our oceans.

A new AI-powered skin patch test for psoriasis just got a major US approval, promising to end costly trial-and-error treatments for millions of patients.

A novel, minimally invasive nerve ablation technology shows long-term promise for relieving severe pancreatic cancer pain, a major unmet medical need.

With a fresh CAD $1M in funding, Grey Matters is set to enter the booming U.S. neuroimaging market, targeting early Alzheimer's detection.

The Pacific Northwest's largest dermatology practice is opening a new clinic in Issaquah, bringing comprehensive skin care to a competitive, growing market.